While the federal government is unwilling to finance its research and leading medical associations have refused to endorse it, medical marijuana is fast growing popular due to its apparent efficacy in alleviating chronic epilepsy in children.
Public opinion against the drug changed three years after a 5-year Colorado girl named Charlotte Figi, who suffers from chronic epilepsy, was shown on social media as positively responding to an oral version of cannabis extract. This saw that marijuana strain, known as Charlotte’s Web, gain widespread media coverage, including by CNN, according to NJ.com.
After intense pressure, the Epilepsy Foundation spoke out, with top leaders of this group that represents 2.5 million people to lobby the federal government to stop considering labeling marijuana as an addictive and harmful drug with no proven medicinal benefit in order to allow research to proceed.
“Nothing should stand in the way of patients gaining access to potentially life-saving treatment,” said Epilepsy Foundation’s Board Director Warren Lammert and President and CEO Philip Gattone, whose children have epilepsy. “If a patient and their healthcare professionals feel that the potential benefits of medical marijuana for uncontrolled epilepsy outweigh the risks, then families need to have that legal option now – not in five years or 10 years.”
So far, only one FDA-commission clinical study that started last fall that is led by New York University neurologist Orrin Devinsky is studying the medical effect of marijuana extract known as cannabidiol. The pure cannabidiol, which is manufactured by UK-based GW Pharmaceuticals, doesn’t give users the characteristic high. To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.
To contact the reporter of this story; Jonathan Millet at firstname.lastname@example.org